Cite

HARVARD Citation

    Cemerski, S. et al. (n.d.). T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record